Shield Lifesciences And Resins Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.40 Cr
- Revenue Growth 114.71%
- Profit Growth 2083.08%
- Ebitda 739.47%
- Net Worth 1574.35%
- Total Assets 285.71%
About Shield Lifesciences And Resins
Shield Lifesciences And Resins Private Limited (SLARPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 09 October 2020 (Four years and four months 7 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.40 Cr.
Shantishwar Patil and Pratibha Patil serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100PN2020PTC194822
-
Company No.
194822
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Oct 2020
-
Date of AGM
18 Aug 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Shield Lifesciences And Resins?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shantishwar Patil
|
Director | 09-Oct-2020 | Current |
|
Pratibha Patil
|
Director | 09-Oct-2020 | Current |
Financial Performance of Shield Lifesciences And Resins.
Shield Lifesciences And Resins Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 114.71% increase. The company also saw a substantial improvement in profitability, with a 2083.08% increase in profit. The company's net worth Soared by an impressive increase of 1574.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shield Lifesciences And Resins?
In 2023, Shield Lifesciences And Resins had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹24.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 2.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Nov 2023 | Hdfc Bank Limited | ₹1.20 Cr | Open |
| 12 Oct 2023 | Hdfc Bank Limited | ₹1.20 Cr | Open |
How Many Employees Work at Shield Lifesciences And Resins?
Shield Lifesciences And Resins has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shield Lifesciences And Resins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shield Lifesciences And Resins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.